This case report describes a rare adverse effect of Hydergin, a drug used to treat peripheral vascular issues. The patient experienced vasospastic changes in the right ring finger, confirmed through arteriography. The condition resolved after stopping the drug. The findings suggest that ergot-based vasodilators may cause localized vasospastic reactions in unusual anatomical sites. The authors propose that this case contributes to the understanding of drug-induced vascular complications and highlights the need for vigilance in prescribing ergot derivatives.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Current understanding of peripheral vasodilators includes known effects on blood flow regulation. Prior research has shown that ergot derivatives can influence vascular tone through serotonin receptor interactions. No prior work had resolved the potential for ergot-based drugs to cause localized vasospastic reactions. This gap motivated the investigation of unusual clinical presentations following ergot administration. Established knowledge includes the role of ergot alkaloids in treating migraines and peripheral vascular disorders. That uncertainty drove the need to document atypical adverse effects. No prior work had confirmed ergot-induced vasospastic changes in digit vasculature. This gap motivated the analysis of a rare clinical scenario involving finger involvement.
Purpose Of The Study:
The aim of this case report is to document a rare adverse effect of Hydergin administration. The specific problem involves a localized vasospastic reaction in a digit. This uncertainty drove the need to confirm the clinical presentation through arteriographic imaging. The motivation stems from the lack of prior documentation of this phenomenon. The goal is to raise awareness among clinicians about ergot-related vasospastic angiitis. This uncertainty drove the decision to present the case with diagnostic confirmation. The motivation is to contribute to the understanding of drug-induced vascular complications. This uncertainty drove the need to highlight an atypical site of involvement.
The case report documents vasospastic angiitis in the right ring finger following Hydergin use, confirmed by arteriography.
Hydergin, a preparation containing dihydroergocristine, dihydroergocryptine, and dihydroergocornine, was implicated in the reaction.
The right ring finger is a rare site for ergot-induced vasospastic changes, highlighting the unusual nature of this presentation.
Arteriographic imaging confirmed the presence of vasospastic changes in the affected digit.
The patient exhibited symptoms consistent with vasospastic angiitis, including localized vascular changes.
Main Methods:
The study involved a single patient receiving Hydergin for peripheral vasodilation. Clinical evaluation included symptom tracking and physical examination findings. Diagnostic confirmation was achieved through arteriographic imaging techniques. The approach focused on correlating clinical signs with imaging results. No prior work had used arteriography to confirm ergot-induced vasospastic changes. The methodology included temporal correlation of drug administration and symptom onset. The approach emphasized the rare anatomical site of involvement. The methodology aimed to establish a causal link between the drug and the observed condition.
Main Results:
Arteriographic imaging revealed vasospastic changes in the right ring finger vasculature. The patient exhibited symptoms consistent with vasospastic angiitis following Hydergin use. The observed condition resolved after discontinuation of the drug. The specific anatomical site of involvement was the right ring finger. The findings suggest a direct pharmacological effect of the ergot alkaloids. The temporal relationship between drug administration and symptom onset was documented. The imaging confirmed the presence of vasospastic changes. The results propose a causal link between Hydergin and the observed vascular reaction.
Conclusions:
The authors propose that Hydergin administration may induce vasospastic angiitis in rare anatomical sites. This finding suggests a potential adverse effect of ergot-based vasodilators. The synthesis of clinical and imaging data supports this implication. The authors propose that clinicians should consider this possibility in atypical presentations. The implications highlight the need for vigilance in drug-induced vascular complications. The authors propose that further case documentation is necessary to confirm this pattern. The findings suggest a need for caution in prescribing ergot derivatives. The authors propose that this case contributes to the pharmacovigilance literature.
Failed At:
2026-07-14T07:53:34.216799+00:00
The authors suggest that ergot-based drugs may cause vasospastic reactions in rare anatomical locations.